amgen

  1. Amgen sees sales fall in some of its biggest established products

    https://alphastreet.com/bite/d578727 Amgen, that is in the process of refreshing their product portfolios, reported higher-than-expected 3Q profit, but sales declined in some of its biggest established products.
    • anonymous
    • Thread
    • amgen biotech drugs earnings health pharma sales stock
    • Replies: 0
    • Forum: Amgen

  2. Mvasi, first direct competitor to a billion-dollar cancer drug

    FDA approves Allergan and Amgen's biosimilar of Roche's Avastin.
    • anonymous
    • Thread
    • allergan amgen cancer treatment fda
    • Replies: 1
    • Forum: Allergan

  3. NovaSeq platform helps Amgen's peer Illumina to raise forecast

    NovaSeq platform was debuted in January with a goal of lowering the cost of sequencing a human genome to $100. Illumina is expecting strong demand for this platform, which helped the firm to raise its outlook for the year. Check out the earnings highlights: https://alphastreet.com/bite/3af2cd8
    • Jim Rogers
    • Thread
    • amgen dna sequencing genomics illumina
    • Replies: 0
    • Forum: Amgen
Top Bottom
Back